Jun 25 |
Is the Options Market Predicting a Spike in Biogen (BIIB) Stock?
|
Jun 24 |
Biogen Inc. (BIIB) is a Top-Ranked Momentum Stock: Should You Buy?
|
Jun 24 |
TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union
|
Jun 19 |
Ionis (IONS) Expands Licensing Deal With Otsuka for HAE Drug
|
Jun 17 |
Two Is Better Than One in the Alzheimer’s Market
|
Jun 17 |
ALS pipeline suffers a major hit as Biogen’s Tofersen fails phase iii trial
|
Jun 15 |
ALS therapy market seen increasing to nearly $1.3B by 2029
|
Jun 14 |
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab (Revised)
|
Jun 14 |
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune (Revised)
|
Jun 13 |
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune
|